Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AUBN vs CBAN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CBAN Wins Head-to-Head Institutional Verdict (3–0 across 6 Pillars · 6–3 Matrix Metrics)

CBAN Overall Winner 6-Pillar Tally: AUBN 0 – 3 CBAN (3 Tie) Matrix Metrics: AUBN 3 – 6 CBAN

As of Nov 20, 2026, Colony Bankcorp Inc. (CBAN) is the stronger overall head-to-head candidate over AUBN (AUBN) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). AUBN carries a Unified Composite Score of 53.7/100 (HOLD) at $24.50 (9.2x Forward P/E, 33.5% operating margin), whereas CBAN carries 44.5/100 (HOLD) at $19.22 (8.0x Forward P/E, 33.4% operating margin).

  • Composite vs. Pillar Nuance: While AUBN currently prints a higher short-term Unified Composite Score (53.7/100 HOLD vs. CBAN 44.5/100 HOLD), CBAN captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–0 across the 6 pillars) due to superior fundamental profitability (33.4% vs. 33.5% operating margin) and revenue trajectory (+26.0% vs. +4.4% YoY).
  • Technical & Structure Timing Caution: AUBN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.6); meanwhile CBAN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AUBN vs CBAN
AUBN US Equity
AUBN
Institutional Equity
$24.50
-2.97% 1D
Market Cap $87.9M
TTM Revenue $34M
Forward P/E 9.2x
Beta / 30D Vol 0.06β · 38% Vol
Unified Composite Score
53.7 / 100 HOLD
Tech 58.0 Fund 57.0 Flow 50.0 Mom 58.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 40
RSI-14: 39.6 · SMA20: $25.85 · SMA50: $26.33
CBAN NYSE Head-to-Head Winner
Colony Bankcorp Inc.
State Commercial Banks
$19.22
-1.99% 1D
Market Cap $535.3M
TTM Revenue $154M
Forward P/E 8.0x
Beta / 30D Vol 0.39β · 19% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 30.0 Fund 46.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 32
RSI-14: 32.4 · SMA20: $20.23 · SMA50: $20.32

6-Pillar Scorecard Institutional Category Breakdown (AUBN 0 – 3 CBAN)

Columns: Metric · AUBN · CBAN
1. Valuation Multiples CBAN
Forward P/E 9.2x 8.0x
Trailing P/E 10.1x 10.8x
PEG Ratio 3.33x 2.11x
EV / Revenue 2.6x 3.5x
2. Growth & Scale CBAN
Revenue Growth (YoY) +4.4% +26.0%
Earnings Growth (YoY) +13.0% +50.2%
TTM Revenue (USD) $34M $154M
Market Cap $87.9M $535.3M
3. Profitability & Quality Tie
Gross Margin 100.0% 100.0%
Operating Margin 33.5% 33.4%
Net Profit Margin 25.2% 24.3%
Return on Equity (ROE) 9.7% 10.8%
4. Balance Sheet & Cash Flow CBAN
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $25.74 Book/Sh · 9.7% ROE $18.46 Book/Sh · 10.8% ROE
Dividend Yield 4.08% 2.39%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 594.7% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity 66.5% of Rev ($23M) 66.6% of Rev ($102M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Banks - Regional Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AUBN (3) vs CBAN (6)
Institutional Metric AUBN CBAN Criterion Row Edge
Market Capitalization
Scale
$87.9M $535.3M Larger Scale CBAN
Trailing P/E Ratio
Valuation
10.1x 10.8x Lower Multiple AUBN
Forward P/E Ratio
Valuation
9.2x 8.0x Lower Multiple CBAN
Revenue Growth (YoY)
Growth
+4.4% +26.0% Higher Growth CBAN
Operating Margin (TTM)
Profitability
33.5% 33.4% Higher Margin Tie
Net Profit Margin
Profitability
25.2% 24.3% Higher Margin AUBN
Return on Equity (ROE)
Capital Efficiency
9.7% 10.8% Higher ROE CBAN
52-Week Range Position
Momentum
44% ($21–$29) 49% ($16–$22) Stronger Trend CBAN
Beta / 30D Volatility
Risk Regime
0.06β · 38% Vol 0.39β · 19% Vol Lower Realized Risk CBAN
Unified Institutional Score
Composite Signal
53.7 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite AUBN
Trailing 12M Revenue (USD)
Operating Scale
$34M $154M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.33x PEG · 2.6x EV/Rev 2.11x PEG · 3.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($25.74 Book/Sh · 9.7% ROE) N/A ($18.46 Book/Sh · 10.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CBAN +6.75 pp
AUBN: -9.19% · CBAN: -2.44%
3M Horizon AUBN +6.03 pp
AUBN: -6.29% · CBAN: -12.32%
6M Horizon AUBN +8.81 pp
AUBN: +5.88% · CBAN: -2.93%
1Y Horizon CBAN +17.91 pp
AUBN: +1.03% · CBAN: +18.94%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AUBN vs CBAN. Trailing 12-month operating profitability (AUBN 33.5% vs CBAN 33.4%) and valuation multiples (AUBN 9.2x vs CBAN 8.0x Forward P/E) are benchmarked directly in Pillar 4 below.

AUBN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$34M
Gross Margin100.0%
Op. Margin33.5%
ROE / Fwd P/E9.7% · 9.2x
CBAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$154M
Gross Margin100.0%
Op. Margin33.4%
ROE / Fwd P/E10.8% · 8.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AUBN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AUBN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CBAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 594.7%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CBAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AUBN Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $87.9M market capitalization and 33.5% operating margin.
OpEx & R&D Reinvestment 66.5% of Rev ($23M)
90D Engineering Disclosures 0 Published
CBAN Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $535.3M market capitalization and 33.4% operating margin.
OpEx & R&D Reinvestment 66.6% of Rev ($102M)
90D Engineering Disclosures 0 Published

Investor FAQ AUBN vs CBAN Key Questions & Quantitative Answers

As of Nov 20, 2026, Colony Bankcorp Inc. (CBAN) is the stronger overall head-to-head candidate over AUBN (AUBN) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). AUBN carries a Unified Composite Score of 53.7/100 (HOLD) at $24.50 (9.2x Forward P/E, 33.5% operating margin), whereas CBAN carries 44.5/100 (HOLD) at $19.22 (8.0x Forward P/E, 33.4% operating margin). Composite vs. Pillar Nuance: While AUBN currently prints a higher short-term Unified Composite Score (53.7/100 HOLD vs. CBAN 44.5/100 HOLD), CBAN captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–0 across the 6 pillars) due to superior fundamental profitability (33.4% vs. 33.5% operating margin) and revenue trajectory (+26.0% vs. +4.4% YoY). Technical & Structure Timing Caution: AUBN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.6); meanwhile CBAN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CBAN leads the Growth & Scale pillar: AUBN posts +4.4% YoY revenue growth and +13.0% YoY earnings growth on $34M TTM revenue (100.0% gross margin, 33.5% operating margin), compared with CBAN at +26.0% YoY revenue growth and +50.2% YoY earnings growth on $154M TTM revenue (100.0% gross margin, 33.4% operating margin). On trailing 12-month operating scale, AUBN generates $34M in USD-normalized revenue versus $154M for CBAN. In operating R&D and SG&A reinvestment, AUBN deploys 66.5% of Rev ($23M) (0 90-day corporate R&D disclosures) versus 66.6% of Rev ($102M) (0 disclosures) for CBAN.

CBAN screens cheaper on headline valuation multiples. AUBN trades at 9.2x Forward P/E, 10.1x Trailing P/E, 3.33x PEG, and 2.6x EV/Revenue (unreported cash flow margin), whereas CBAN trades at 8.0x Forward P/E, 10.8x Trailing P/E, 2.11x PEG, and 3.5x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AUBN (9.7% ROE) versus CBAN (10.8% ROE) capital efficiency.

In options market volatility and institutional positioning, AUBN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.06β · 38% Vol realized risk). By comparison, CBAN carries 594.7% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.39β · 19% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.